The NTAGI has now not but urged any exchange within the agenda of Bharat Biotech's Covaxin, whose 2nd dose is run 28 days after the primary dose.
Your Global Perspective
Your Global Perspective
The NTAGI has now not but urged any exchange within the agenda of Bharat Biotech's Covaxin, whose 2nd dose is run 28 days after the primary dose.